Chapter 20: Pentose Phosphate Pathway & Hexose Metabolism

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

We usually think of glucose as, you know, pure energy.

We eat it, our cells run it through glycolysis, then the citric acid cycle.

And bam, a massive amount of ATP is generated.

Exactly.

But what if your body needs to build complex structures or defend itself from toxins rather than just generating power?

Right.

What happens when glucose takes a critical metabolic detour, sacrificing that immediate energy for the tools needed to, well, build and protect the entire cell?

That metabolic detour is precisely what we're diving into today.

The pentose phosphate pathway or PPP.

This is arguably one of the most crucial non -ATP generating pathways in your body.

Our mission is to understand how the PPP, along with these alternative pathways for other sugars like fructose and galactose, actually function.

These rats are silent workhorses and when they fail, the clinical consequences are huge, profound.

They range from things like gout all the way to severe hemolytic anemia.

So the goal is an immediate energy.

If we zoom out, what are the two absolute non -negotiable end products of the PPP that make it so vital?

The pathway is essential for two main things.

First, the primary product is NADPH.

NADPH, not NADH.

Exactly.

This is the specialized reduced coenzyme that acts as the cell's internal reducing power.

It's required for all major reductive syntheses.

So like building fats, building steroids.

Exactly.

And critically, for maintaining the reduced state of glutathione, which is our cell's master antioxidant defense system.

Okay, that's one.

And the second product.

That would be ribose, specifically ribose five phosphate.

This is the essential five carbon sugar precursor for the backbone of all your nucleotides and nucleic acids.

RNA, DNA.

All of it.

Plus essential coenzymes like FAD and NAD+.

Basically, if you're building new cells, you need the PPP running.

That immediately clarifies its importance.

If this pathway is so focused on building and defense, how does it physically differ from the familiar path of glycolysis?

Let's break down the mechanism.

Well, the mechanics are distinct, though the location isn't.

Okay.

Like glycolysis, all the enzymes of the PPP are found right there in the cell's cytosol.

So they're all mixed in together.

They are.

But the fundamental difference is the coenzyme used for oxidation.

Glycolysis uses NAD +, to extract electrons and capture energy.

The PPP uses NADP +, as its hydrogen acceptor.

Which generates the NADPH we just mentioned.

Precisely.

And that NADPH is designed to donate electrons for building things.

No ATP is generated or consumed directly in the pathway.

It sounds like we have two major phases based on the source material.

One that makes the NADPH and one that rearranges the sugars.

That's a perfect breakdown.

The first phase is the irreversible oxidative phase.

And we can definitely call this the NADPH generator.

Okay.

So three molecules of glucose, six phosphate enter this phase.

Which means we start with the exact same compound as glycolysis.

Exactly the same.

The first and most critical step is the dehydrogenation of that glucose six phosphate.

It's catalyzed by glucose six phosphate dehydrogenase or G6PD.

G6PD.

That's the one we hear about clinically.

This is the big one.

It's the rate limiting committing step and it requires NADP+.

That reaction yields your first molecule of NADPH.

Then a second, similar oxidative step follows.

Catalyzed by six phosphogluconate dehydrogenase.

This results in the five carbon sugar ribulose five phosphate and it releases a molecule of CO2.

So we're losing a carbon.

We are.

The net result of this whole phase is three CO2 molecules and six molecules of NADPH for every three glucose six phosphates that you process.

It sounds like the cell is making a definitive choice here.

Yeah.

Use G6PD, commit to NADPH and just skip making ATP.

You mentioned the G6PD enzyme is a central gatekeeper.

Is it only in the cytosol?

Well G6PD is the star in the cytosol but there's a fascinating supporting player.

An isoenzyme, hexo six phosphate dehydrogenase which operates in the endoplasmic reticulum.

Oh interesting.

Yeah it fulfills the same function generating NADPH but in a different compartment.

That localized NADPH is essential for hydroxylation reactions and notably for activating cortisone into its active form cortisol.

So a completely separate pool of reducing power just for specific localized jobs.

Exactly a parallel system.

That's a great detail.

Now let's move into the second part of the pathway, the non -oxidative phase.

If the NADPH is already made what's the point here?

This phase is all about resource management.

It's reversible and its goal is to take that five carbon sugar, ribulose five phosphate and either isomerize it directly into ribose five phosphate.

For DNA and RNA.

Right or rearrange those C5 sugars back into C6 or C3 sugars that can jump back into glycolysis.

Think of it as a metabolic shuffler just balancing the cell's needs.

How does that shuffling happen?

It sounds good.

It relies on two remarkable enzymes.

First you have transketolase.

Transketolase.

It does exactly what its name implies.

It transfers a two carbon unit from one sugar to another.

And transketolase has a really famous nutritional connection right?

Absolutely.

Transketolase requires magnesium and thiamin phosphate which you know comes from vitamin B1 as a coenzyme.

Okay.

And because thiamin is so essential for it, measuring how much thiamin phosphate activates transketolase in your red blood cells is a classic high yield clinical index of your vitamin B1 status.

That's a perfect connection from basic chemistry right to clinical nutrition.

So what's the other shuffler enzyme?

That's transaldolis which transfers a three carbon unit.

Now the chemistry is a bit involved but the C5 sugars and effectively stitch them together or pull them apart.

So they can mix and match.

Exactly.

They can take two C5 sugars and make a C6 and a C4 for example.

The overall result is the formation of fructose 6 phosphate and glyceraldehyde 3 phosphate.

Which are glycolytic intermediates.

Right.

This allows the carbon atoms that started as glucose to loop right back into glycolysis if the cell isn't dividing and doesn't need all that ribose.

So we can summarize the PPP as this incredibly flexible system.

It produces two distinct products NADPH and ribose and it can adjust its output based on what the cell needs at that moment.

Precisely.

It's constantly adjusting its gears.

That adaptability leads to the next question.

Why do certain tissues rely on this more than others?

Where is this pathway running at maximum speed?

We see really high PPP activity in tissues that are constantly synthesizing things.

Specifically tissues that specialize in reductive syntheses.

So we're talking about?

Think about the liver, adipose tissue, the adrenal cortex, the thyroid, the testis or a lactating mammary gland.

All of these need huge amounts of NADPH to make fatty acids, steroid hormones or milk.

And I assume tissues like muscle have low activity.

Very low activity.

Skeletal muscle is focused on energy not synthesis.

The function really dictates the flux.

Given that the liver and adipose tissue crank this pathway up when storing energy, how is it regulated by our nutritional state?

How does the body know to start making fat?

The regulation is tied directly to the fed state.

The synthesis of both G6PD and 6 -phosphogluconate dehydrogenase, those two key oxidative enzymes, can be induced by insulin.

Ah, insulin.

Makes sense.

When you have high carbs and high insulin, the body is getting the signal to store energy.

Increasing these enzymes correlates perfectly with increased lipogenesis or fat

That makes perfect sense.

But you mentioned a fascinating bit of crosstalk back to glycolysis earlier.

How does the PPP signal glycolysis to speed up?

This is one of the coolest parts.

Remember xylulose 5 -phosphate, one of those C5 intermediates.

It doesn't just shuffle sugars.

It acts as a genuine signal molecule.

A signal.

Yes.

When glucose is abundant and the PPP is running, xylulose 5 -phosphate levels rise.

This pentose then activates a protein phosphatase, which ultimately leads to an increased concentration of fructose 2 .6 -bisphosphate.

And fructose 2 .6 -bisphosphate is that powerful activator of glycolysis.

It's a powerful allosteric activator of phosphofructokinase 1, PFK1, the major regulatory enzyme.

So in effect, the PPP is sending a memo back to glycolysis saying, hey, we have plenty of carbon here, step on the gas.

It coordinates both storage and energy generation at the same time.

It's the ultimate metabolic traffic.

Now let's pivot to the red blood cell because this is where the PPP shifts from being a resource manager to an absolute body card.

Absolutely critical.

Erythrocytes, red blood cells are unique because the PPP is their sole source of NADPH.

Their only source.

Wow.

Their only source.

Since they have no nucleus or mitochondria, they have no other way to make this reducing power.

And they need it desperately because they are constantly exposed to high oxygen, which creates a ton of oxidative damage.

So if I'm a red blood cell, what's my biggest threat and how does NADPH protect me?

Your biggest internal threat is hydrogen peroxide, H2O2, and other reactive oxygen species.

Your defense system relies entirely on reduced glutathione, or GSH.

GSH acts as a sacrificial electron donor to neutralize these dangerous peroxides in a reaction catalyzed by glutathione peroxidase.

And what happens to the glutathione in that process?

The reduced glutathione, GSH, becomes oxidized glutathione, that's where the PPP comes in.

NADPH is used by the enzyme glutathione reductase to immediately reduce that GSH back to GSH, restarting the cycle.

So the cycle is non -stop.

It has to be.

It's the preliminary way the cell handles oxidative stress.

So the chain is clear.

G6PD makes NADPH, NADPH reduces GSH, and GSH neutralizes the H2O2.

So if you lack G6PD, what's the end result?

The cycle just stops.

H2O2 accumulates because the body can't regenerate GSH fast enough, and the peroxides cause irreversible damage to the cell membrane, leading directly to hemolysis, the catastrophic destruction of the red blood cell.

That's the core clinical link.

Now that we've established the PPP, let's look at two other detours glucose can take, starting with the uronic acid pathway.

What's its unique role?

The uronic acid pathway is another oxidative route for glucose, totally separate from the others.

Its main function is not energy or ribose, but detoxification.

It converts glucose into glucuronic acid.

And why is glucuronic acid so vital for detox?

The key functional molecule is UDP glucuronate.

This compound provides the glucuronate group for conjugation reactions.

Conjugation meaning adding it onto other molecules.

Exactly.

The body attaches this highly water -soluble glucuronate to hydrophobic things like steroids, bilirubin, and especially foreign chemicals, xenobiotics, making them highly polar.

They can be excreted.

Right.

Once conjugated, these toxic compounds are efficiently excreted in the urine or bile.

It's the body's primary system for tagging things for removal.

We also hear about this pathway in the context of vitamin C.

What's that connection?

Glucuronate is actually a precursor in the biochemical path to ascorbic acid, or vitamin C.

However, humans, unlike most mammals, cannot synthesize our own

because we're missing an enzyme.

We are.

We lack the final enzyme in that pathway.

Yeah.

That missing enzyme is why vitamin C is an essential vitamin for us.

Okay.

Moving on, let's look at fructose.

This sugar, especially from high fructose syrups, gets a bad rap.

Is that justified?

It is largely justified.

And your previous analogy was spot on.

Fructose acts like a metabolic hot rod that ignores all the speed limits in the liver.

It's metabolized so much faster than glucose, and that speed is the problem.

How does it manage to speed past the controls?

Glucose metabolism is tightly regulated at the PFK1 step.

That's the master switch.

Fructose, however, is first phosphorylated by fructokinase to form fructose 1 phosphate.

Critically, this step is not regulated by the cell's energy needs.

Okay.

Then the F1P is cleaved by aldolase B directly into C3 sugars that are already downstream of that PFK1 control point.

So fructose completely bypasses the most important regulatory checkpoint in glycolysis.

So by bypassing TFK1, the liver is just flooded with carbon units that it has to process.

What are the consequences of that?

The consequences are twofold, and they're both serious.

First, that rapid influx of carbon accelerates fatty acid synthesis.

This massively increases the liver's output of VLDL.

Very low density lipoproteins.

Right.

Leading to hypertriacylglycerinemia, high fat in the blood, and contributes to dyslipidemia.

And the second major consequence.

This one relates to gout, correct?

Yes.

This is a subtle but destructive effect.

When fructokinase rapidly phosphorylates fructose, it sequesters inorganic phosphate inside the cell.

The cell's ATP synthesis is diminished.

And that causes stress.

Huge stress.

This reduces the inhibition of purine synthesis.

The end result is a rapid breakdown of purines, leading to increased production and accumulation of uric acid hyperuricemia, which is the direct precursor of gout.

A profound series of knock -on effects from one metabolic bypass.

Now let's consider galactose, the milk sugar.

Is it equally aggressive?

Galactose is much more orderly.

It comes from lactose and is readily converted into glucose in the liver.

It starts with galactokinase, which converts it to galactose -1 -phosphate.

Then the key enzyme, galactose -1 -phosphate uridolatransferase, converts it to UDP galactose.

What's the cell doing with UDP galactose?

It sounds like another activated intermediate.

It is.

Galactose isn't just for burning.

UDP galactose is essential for building things.

It's used to synthesize lactose in the mammary gland.

And more broadly, it's a necessary component of crucial structural molecules.

Glycolipids, proteoglycans, glycoproteins.

So it's a building block.

It's a key building block.

And quickly, we also have amino sugars or hexosamines.

Where do they fit in?

They're structurally related and are also synthesized from glucose.

These amino sugars, like glucosamine and cialic acid, are fundamental components of glycoproteins and glycosfingal lipids, which are essential for cell recognition.

Okay, so we've discussed several choke points.

Now let's dive into the major inherited diseases that arise when these pathways fail.

We started with G6PD deficiency.

Let's finish that story.

Glucose 6 -phosphate dehydrogenase deficiency is statistically huge.

It's the most common genetic defect worldwide, affecting over 400 million people.

And because the gene is X -linked, it primarily impacts males.

And it all comes down to not making enough NADPH.

Exactly.

So when does this genetic vulnerability become a clinical crisis?

It becomes a crisis when the patient encounters any source of oxidative stress.

Like what?

An infection, certain anti -malarial drugs like primakines, sulfa drugs, or even eating fava beans, which is why it's commonly known as fabism.

These stressors generate reactive oxygen faster than the cell can handle them, causing explosive hemolysis.

Are all versions of this deficiency equally severe?

No, they are not.

And that's a critical point.

The variant common in the Afro -Caribbean population involves an enzyme that's unstable.

So it breaks down over time.

Right.

So it's the older red blood cells that are in trouble.

The crisis tends to be self -limiting as new functional red cells replace the old ones.

But the Mediterranean variant?

That's much more severe.

Here, the enzyme is stable but has very low activity in all red blood cells from the start.

Any oxidative stress can trigger a massive, severe, and potentially fatal hemolytic crisis.

That's a crucial distinction.

Let's look at the defective sugar metabolisms next.

For fructose, we have to distinguish between two conditions.

The benign one is essential fructosuria, a lack of fructokinase.

Fructose just spills harmlessly into the urine.

Okay, so that was not a big problem.

Right.

The dangerous one is hereditary fructose intolerance, caused by a deficiency in aldolase B.

And if aldolase B is absent, what builds up?

Fructose 1 -phosphate accumulates uncontrollably.

This accumulation is toxic.

It inhibits liver glycogen phosphorylase, leading to severe, profound hypoglycemia after eating any fructose.

And it also causes the hyperuricemia we talked about.

Exactly.

Due to the phosphate depletion.

And finally, the consequences of defective galactose metabolism.

That's galactosemia, typically from a severe defect in the galactose 1 -phosphate uradil transferase enzyme.

And similar to fructose intolerance, the metabolite galactose 1 -phosphate accumulates.

Causing what kind of damage?

Severe systemic issues.

Liver failure, mental deterioration, all due to that resulting phosphate depletion.

And the symptom that often leads to diagnosis in infants.

The hallmark symptom is the formation of cataracts.

The accumulating galactose is converted by an enzyme, aldose reductase, into galactitol.

Galactitol.

Right.

And galactitol is osmotically active and it accumulates inside the lens of the eye, causing water to rush in, which leads to cataracts.

And this is the exact same aldose reductase responsible for making sorbitol from high glucose in diabetes.

This is a common mechanism of damage.

What a dense and surprisingly intertwined system this is.

Let's recap the three main pathways.

To summarize, the pentose phosphate pathway is the cell's primary source of defense.

That's NADPH in construction, which is rebose.

Its gatekeeper, G6PD, is non -negotiable for red blood cell survival.

And the uronic acid pathway is our body's essential detoxification route, letting us excrete hormones and foreign chemicals.

Exactly.

And the other hexose pathways are governed by either strict or, in fructose's case, non -existent regulation.

Right.

Fructose, by bypassing PFK1, is metabolically aggressive, powerfully stimulating fat synthesis, and increasing the risk of gout.

While dilactosemia and hereditary fructose intolerance both show how the accumulation of a toxic phosphorylated intermediate can cause massive systemic failures.

So what we've seen today is that defects in these seemingly minor metabolic routes pathways that don't directly make ATP can cause catastrophic failures.

You now understand the invisible metabolic cost of eating fructose and the constant hidden antioxidant defense running inside your red cells.

It puts the entire concept of glucose utilization into a whole new context.

So what does this all mean for the bigger picture?

Considering that xylose -5 -phosphate acts as a crucial signal to increase both glycolysis and fat synthesis,

this simple pentose is a key communication link between carb availability,

energy generation, and fat storage.

How might we leverage this specific signaling pathway, the xylose -5 -phosphate sensor, to target and potentially treat metabolic diseases like obesity or type 2 diabetes?

That is something powerful for you to consider as you continue your studies.

Thank you for joining us for the deep dive.

We'll see you next time.